SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - BIT:1SAN - FR0000120578 - Common Stock
80.14 EUR
-1.06 (-1.31%)
1SAN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 49 industry peers in the Pharmaceuticals industry. 1SAN has an excellent profitability rating, but there are some minor concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. 1SAN also has an excellent dividend rating. With these ratings, 1SAN could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
1SAN has a better Return On Assets (11.05%) than 81.63% of its industry peers.
1SAN has a Return On Equity of 19.73%. This is in the better half of the industry: 1SAN outperforms 71.43% of its industry peers.
With a decent Return On Invested Capital value of 13.84%, 1SAN is doing good in the industry, outperforming 73.47% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 15.25%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
Looking at the Profit Margin, with a value of 20.35%, 1SAN belongs to the top of the industry, outperforming 81.63% of the companies in the same industry.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
Looking at the Operating Margin, with a value of 23.59%, 1SAN is in the better half of the industry, outperforming 63.27% of the companies in the same industry.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin (71.70%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
1SAN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, 1SAN belongs to the top of the industry, outperforming 83.67% of the companies in the same industry.
1SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1SAN (0.21) is better than 73.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC7.44%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1SAN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, 1SAN is in line with its industry, outperforming 44.90% of the companies in the same industry.
1SAN has a Quick Ratio of 1.27. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1SAN (0.94) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -2.20% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
The Revenue has been growing slightly by 6.45% in the past year.
Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
The Earnings Per Share is expected to grow by 6.41% on average over the next years.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.61, the valuation of 1SAN can be described as very reasonable.
83.67% of the companies in the same industry are more expensive than 1SAN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.30. 1SAN is valued rather cheaply when compared to this.
1SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.19.
Based on the Price/Forward Earnings ratio, 1SAN is valued cheaply inside the industry as 81.63% of the companies are valued more expensively.
1SAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.61 | ||
| Fwd PE | 9.19 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, 1SAN is valued a bit cheaper than 61.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.41 | ||
| EV/EBITDA | 10.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)2.72
PEG (5Y)2.08
EPS Next 2Y6.53%
EPS Next 3Y6.33%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.86%, 1SAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.04, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 87.76% of the companies listed in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.86% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
BIT:1SAN (9/10/2025, 7:00:00 PM)
80.14
-1.06 (-1.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap195.46B
Analysts80
Price Target109.75 (36.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.86% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)1.11%
PT rev (3m)-9.51%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.61 | ||
| Fwd PE | 9.19 | ||
| P/S | 2.88 | ||
| P/FCF | 19.41 | ||
| P/OCF | 17.18 | ||
| P/B | 2.79 | ||
| P/tB | 21.03 | ||
| EV/EBITDA | 10.32 |
EPS(TTM)7.55
EY9.42%
EPS(NY)8.72
Fwd EY10.88%
FCF(TTM)4.13
FCFY5.15%
OCF(TTM)4.67
OCFY5.82%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.72
PEG (5Y)2.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.44%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%